PRICE T ROWE ASSOCIATES INC /MD/ - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$118
-96.9%
29,789
-91.7%
0.00%
-100.0%
Q2 2023$3,816
+21.2%
358,922
-5.0%
0.00%
Q1 2023$3,148
-13.7%
377,801
-4.4%
0.00%
-100.0%
Q4 2022$3,647
-99.9%
395,107
-4.2%
0.00%0.0%
Q3 2022$5,295,000
-3.8%
412,343
-1.1%
0.00%0.0%
Q2 2022$5,505,000
-38.3%
416,721
-1.7%
0.00%0.0%
Q1 2022$8,922,000
-15.1%
423,863
-3.3%
0.00%0.0%
Q4 2021$10,514,000
+22.4%
438,247
+29.8%
0.00%0.0%
Q3 2021$8,588,000
-34.1%
337,582
-12.9%
0.00%0.0%
Q2 2021$13,041,000
-46.1%
387,423
-37.8%
0.00%
-50.0%
Q1 2021$24,205,000
-47.9%
623,192
-16.9%
0.00%
-60.0%
Q4 2020$46,424,000
+274.6%
749,626
+102.6%
0.01%
+400.0%
Q3 2020$12,394,000
+32.9%
370,093
-5.4%
0.00%0.0%
Q2 2020$9,326,000
-4.7%
391,358
-8.5%
0.00%
-50.0%
Q1 2020$9,790,000
-29.2%
427,522
-12.5%
0.00%0.0%
Q4 2019$13,835,000
+68.4%
488,513
+27.8%
0.00%
+100.0%
Q3 2019$8,216,000
-25.3%
382,313
+1.4%
0.00%
-50.0%
Q2 2019$10,994,000376,9000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders